dr. weinberg on the role of cetuximab in metastatic crc
Published 4 years ago • 154 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
1:06
evaluating the role of cetuximab in metastatic colorectal cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
1:50
dr. benson on sequencing strategies with cetuximab in crc
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
16:01
colorectal cancer: ask dr. ben weinberg
-
2:42
dr. bekaii-saab discusses an analysis of bevacizumab or cetuximab for crc
-
3:02
final thoughts on the treatment of metastatic colorectal cancer
-
8:41
calgb 80405 trial results in metastatic colorectal cancer
-
6:10
continuum of care for metastatic crc
-
5:27
epoc studies: preoperative cetuximab in kras wild-type colorectal cancer
-
9:00
first- and later-line use of panitumumab in metastatic colorectal cancer
-
4:31
cetuximab and chemoradiation
-
5:36
pathways of resistance in metastatic colorectal cancer
-
1:06
comment: ftd/tpi bev ftd/tpi provides benefits for metastatic colorectal cancer patients
-
0:57
dr. peeters discusses the efficacy and safety of panitumumab versus cetuximab in colorectal cancer
-
1:13
dr. lenz on breakthrough designation of encorafenib, binimetinib, and cetuximab in braf crc
-
8:19
cetuximab use for hnscc